Pyruvate suppresses PGC1α expression and substrate utilization despite increased respiratory chain content in C2C12 myotubes

Andrew Philp, Joaquin Perez-Schindler, Charlotte Green, D. Lee Hamilton, Keith Baar

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Sodium pyruvate can increase mitochondrial biogenesis in C2C12 myoblasts in a peroxisome proliferator-activated receptor-γ coactivator-1α (PGC1α)-independent manner. The present study examined the effect of 72-h treatment with sodium pyruvate (5-50 mM) or sodium chloride (50 mM) as an osmotic control on the regulation of mitochondrial substrate metabolism and biogenesis in C2C12 myotubes. Pyruvate (50 mM) increased the levels of fatty acid oxidation enzymes (CD36, 61%, and β-oxidative enzyme 3-hydroxyacyl-CoA dehydrogenase, 54%) and the expression of cytochrome-c oxidase subunit I (220%) and cytochrome c (228%), consistent with its previous described role as a promoter of mitochondrial biogenesis. However, in contrast, pyruvate treatment reduced glucose transporter 4 (42%), phosphofructokinase (57%), and PGC1α (72%) protein content as well as PGC1α (48%) and PGC1β (122%) mRNA. The decrease in PGC1α was compensated for by an increase in the PGC1α-related coactivator (PRC; 187%). Pyruvate treatment reduced basal and insulin-stimulated glucose uptake (41% and 31%, respectively) and palmitate uptake and oxidation (24% and 31%, respectively). The addition of the pyruvate dehydrogenase activator dichloroacetate (DCA) and the TCA precursor glutamine increased PGC1α expression (368%) and returned PRC expression to basal. Glucose uptake increased by 4.2-fold with DCA and glutamine and palmitate uptake increased by 18%. Coupled to this adaptation was an 80% increase in oxygen consumption. The data suggest that supraphysiological doses of pyruvate decrease mitochondrial function despite limited biogenesis and that anaplerotic agents can reverse this effect.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Cell Physiology
Volume299
Issue number2
DOIs
StatePublished - Aug 2010
Externally publishedYes

Fingerprint

Skeletal Muscle Fibers
Electron Transport
Pyruvic Acid
Palmitates
Organelle Biogenesis
Glutamine
3-Hydroxyacyl-CoA Dehydrogenase
Sodium
Glucose
Phosphofructokinases
Peroxisome Proliferator-Activated Receptors
Facilitative Glucose Transport Proteins
Myoblasts
Electron Transport Complex IV
Enzymes
Cytochromes c
Sodium Chloride
Oxygen Consumption
Fatty Acids
Insulin

Keywords

  • Glucose metabolism
  • Glutamine
  • Peroxisome proliferator-activated receptor-γ coactivator-1α
  • Type 2 diabetes

ASJC Scopus subject areas

  • Cell Biology
  • Physiology
  • Medicine(all)

Cite this

Pyruvate suppresses PGC1α expression and substrate utilization despite increased respiratory chain content in C2C12 myotubes. / Philp, Andrew; Perez-Schindler, Joaquin; Green, Charlotte; Hamilton, D. Lee; Baar, Keith.

In: American Journal of Physiology - Cell Physiology, Vol. 299, No. 2, 08.2010.

Research output: Contribution to journalArticle

Philp, Andrew ; Perez-Schindler, Joaquin ; Green, Charlotte ; Hamilton, D. Lee ; Baar, Keith. / Pyruvate suppresses PGC1α expression and substrate utilization despite increased respiratory chain content in C2C12 myotubes. In: American Journal of Physiology - Cell Physiology. 2010 ; Vol. 299, No. 2.
@article{d94c8b7ee4904b57aab847b81a0f833e,
title = "Pyruvate suppresses PGC1α expression and substrate utilization despite increased respiratory chain content in C2C12 myotubes",
abstract = "Sodium pyruvate can increase mitochondrial biogenesis in C2C12 myoblasts in a peroxisome proliferator-activated receptor-γ coactivator-1α (PGC1α)-independent manner. The present study examined the effect of 72-h treatment with sodium pyruvate (5-50 mM) or sodium chloride (50 mM) as an osmotic control on the regulation of mitochondrial substrate metabolism and biogenesis in C2C12 myotubes. Pyruvate (50 mM) increased the levels of fatty acid oxidation enzymes (CD36, 61{\%}, and β-oxidative enzyme 3-hydroxyacyl-CoA dehydrogenase, 54{\%}) and the expression of cytochrome-c oxidase subunit I (220{\%}) and cytochrome c (228{\%}), consistent with its previous described role as a promoter of mitochondrial biogenesis. However, in contrast, pyruvate treatment reduced glucose transporter 4 (42{\%}), phosphofructokinase (57{\%}), and PGC1α (72{\%}) protein content as well as PGC1α (48{\%}) and PGC1β (122{\%}) mRNA. The decrease in PGC1α was compensated for by an increase in the PGC1α-related coactivator (PRC; 187{\%}). Pyruvate treatment reduced basal and insulin-stimulated glucose uptake (41{\%} and 31{\%}, respectively) and palmitate uptake and oxidation (24{\%} and 31{\%}, respectively). The addition of the pyruvate dehydrogenase activator dichloroacetate (DCA) and the TCA precursor glutamine increased PGC1α expression (368{\%}) and returned PRC expression to basal. Glucose uptake increased by 4.2-fold with DCA and glutamine and palmitate uptake increased by 18{\%}. Coupled to this adaptation was an 80{\%} increase in oxygen consumption. The data suggest that supraphysiological doses of pyruvate decrease mitochondrial function despite limited biogenesis and that anaplerotic agents can reverse this effect.",
keywords = "Glucose metabolism, Glutamine, Peroxisome proliferator-activated receptor-γ coactivator-1α, Type 2 diabetes",
author = "Andrew Philp and Joaquin Perez-Schindler and Charlotte Green and Hamilton, {D. Lee} and Keith Baar",
year = "2010",
month = "8",
doi = "10.1152/ajpcell.00438.2009",
language = "English (US)",
volume = "299",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "2",

}

TY - JOUR

T1 - Pyruvate suppresses PGC1α expression and substrate utilization despite increased respiratory chain content in C2C12 myotubes

AU - Philp, Andrew

AU - Perez-Schindler, Joaquin

AU - Green, Charlotte

AU - Hamilton, D. Lee

AU - Baar, Keith

PY - 2010/8

Y1 - 2010/8

N2 - Sodium pyruvate can increase mitochondrial biogenesis in C2C12 myoblasts in a peroxisome proliferator-activated receptor-γ coactivator-1α (PGC1α)-independent manner. The present study examined the effect of 72-h treatment with sodium pyruvate (5-50 mM) or sodium chloride (50 mM) as an osmotic control on the regulation of mitochondrial substrate metabolism and biogenesis in C2C12 myotubes. Pyruvate (50 mM) increased the levels of fatty acid oxidation enzymes (CD36, 61%, and β-oxidative enzyme 3-hydroxyacyl-CoA dehydrogenase, 54%) and the expression of cytochrome-c oxidase subunit I (220%) and cytochrome c (228%), consistent with its previous described role as a promoter of mitochondrial biogenesis. However, in contrast, pyruvate treatment reduced glucose transporter 4 (42%), phosphofructokinase (57%), and PGC1α (72%) protein content as well as PGC1α (48%) and PGC1β (122%) mRNA. The decrease in PGC1α was compensated for by an increase in the PGC1α-related coactivator (PRC; 187%). Pyruvate treatment reduced basal and insulin-stimulated glucose uptake (41% and 31%, respectively) and palmitate uptake and oxidation (24% and 31%, respectively). The addition of the pyruvate dehydrogenase activator dichloroacetate (DCA) and the TCA precursor glutamine increased PGC1α expression (368%) and returned PRC expression to basal. Glucose uptake increased by 4.2-fold with DCA and glutamine and palmitate uptake increased by 18%. Coupled to this adaptation was an 80% increase in oxygen consumption. The data suggest that supraphysiological doses of pyruvate decrease mitochondrial function despite limited biogenesis and that anaplerotic agents can reverse this effect.

AB - Sodium pyruvate can increase mitochondrial biogenesis in C2C12 myoblasts in a peroxisome proliferator-activated receptor-γ coactivator-1α (PGC1α)-independent manner. The present study examined the effect of 72-h treatment with sodium pyruvate (5-50 mM) or sodium chloride (50 mM) as an osmotic control on the regulation of mitochondrial substrate metabolism and biogenesis in C2C12 myotubes. Pyruvate (50 mM) increased the levels of fatty acid oxidation enzymes (CD36, 61%, and β-oxidative enzyme 3-hydroxyacyl-CoA dehydrogenase, 54%) and the expression of cytochrome-c oxidase subunit I (220%) and cytochrome c (228%), consistent with its previous described role as a promoter of mitochondrial biogenesis. However, in contrast, pyruvate treatment reduced glucose transporter 4 (42%), phosphofructokinase (57%), and PGC1α (72%) protein content as well as PGC1α (48%) and PGC1β (122%) mRNA. The decrease in PGC1α was compensated for by an increase in the PGC1α-related coactivator (PRC; 187%). Pyruvate treatment reduced basal and insulin-stimulated glucose uptake (41% and 31%, respectively) and palmitate uptake and oxidation (24% and 31%, respectively). The addition of the pyruvate dehydrogenase activator dichloroacetate (DCA) and the TCA precursor glutamine increased PGC1α expression (368%) and returned PRC expression to basal. Glucose uptake increased by 4.2-fold with DCA and glutamine and palmitate uptake increased by 18%. Coupled to this adaptation was an 80% increase in oxygen consumption. The data suggest that supraphysiological doses of pyruvate decrease mitochondrial function despite limited biogenesis and that anaplerotic agents can reverse this effect.

KW - Glucose metabolism

KW - Glutamine

KW - Peroxisome proliferator-activated receptor-γ coactivator-1α

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=77955882819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955882819&partnerID=8YFLogxK

U2 - 10.1152/ajpcell.00438.2009

DO - 10.1152/ajpcell.00438.2009

M3 - Article

C2 - 20410436

AN - SCOPUS:77955882819

VL - 299

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 2

ER -